Janney Montgomery Scott
SGMO

Janney Montgomery Scott’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Janney Montgomery Scott’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,145
Closed -$89K – 2634
2022
Q3 		$89K Sell
18,145
-25,600
-59% -$132K ﹤0.01% 2414
2022
Q2 		$179K Sell
43,745
-11,400
-21% -$49.3K ﹤0.01% 2166
2022
Q1 		$320K Sell
55,145
-8,125
-13% -$48.3K ﹤0.01% 1853
2021
Q4 		$475K Sell
63,270
-1,800
-3% -$15.6K ﹤0.01% 1754
2021
Q3 		$586K Buy
+65,070
New +$643K ﹤0.01% 1556
2020
Q1 		– Sell
-10,333
Closed -$86K – 2068
2019
Q4 		$86K Hold
10,333
– – ﹤0.01% 2017
2019
Q3 		$94K Sell
10,333
-45
-0.4% -$505 ﹤0.01% 1990
2019
Q2 		$112K Sell
10,378
-550
-5% -$5.85K ﹤0.01% 1988
2019
Q1 		$104K Sell
10,928
-100
-0.9% -$1.02K ﹤0.01% 1943
2018
Q4 		$127K Hold
11,028
– – ﹤0.01% 1841
2018
Q3 		$187K Hold
11,028
– – ﹤0.01% 1936
2018
Q2 		$157K Sell
11,028
-150
-1% -$2.49K ﹤0.01% 1901
2018
Q1 		$212K Sell
11,178
-350
-3% -$7.48K ﹤0.01% 1790
2017
Q4 		$189K Hold
11,528
– – ﹤0.01% 1812
2017
Q3 		$173K Sell
11,528
-150
-1% -$1.66K ﹤0.01% 1731
2017
Q2 		$103K Hold
11,678
– – ﹤0.01% 1694
2017
Q1 		$61K Sell
11,678
-100
-0.8% -$401 ﹤0.01% 1715
2016
Q4 		$36K Sell
11,778
-1,950
-14% -$7.1K ﹤0.01% 1663
2016
Q3 		$64K Sell
13,728
-15,828
-54% -$80.5K ﹤0.01% 1497
2016
Q2 		$172K Buy
29,556
+13,878
+89% +$88.5K ﹤0.01% 609
2016
Q1 		$95K Buy
15,678
+500
+3% +$3K ﹤0.01% 1222
2015
Q4 		$139K Buy
15,178
+200
+1% +$1.54K ﹤0.01% 1286
2015
Q3 		$84K Sell
14,978
-72
-0.5% -$594 ﹤0.01% 1347
2015
Q2 		$167K Sell
15,050
-500
-3% -$6.45K ﹤0.01% 1858
2015
Q1 		$244K Sell
15,550
-1,000
-6% -$15.5K ﹤0.01% 1932
2014
Q4 		$252K Buy
16,550
+500
+3% +$6.07K 0.01% 1825
2014
Q3 		$173K Buy
16,050
+500
+3% +$6.53K ﹤0.01% 2034
2014
Q2 		$237K Buy
15,550
+1,100
+8% +$15.8K 0.01% 1817
2014
Q1 		$261K Hold
14,450
– – 0.01% 1560
2013
Q4 		$201K Hold
14,450
– – 0.01% 1736
2013
Q3 		$152K Buy
+14,450
New +$144K ﹤0.01% 1728

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janney Montgomery Scott's SGMO Position: Q4 2022 in Review

Janney Montgomery Scott sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 18,145 shares — an estimated $89K sold.

Janney Montgomery Scott first reported a position in SGMO in Q3 2013 and held it in 31 quarters. The position peaked at $586K in Q3 2021. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Janney Montgomery Scott reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 18,145 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $89K.
  • Janney Montgomery Scott first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 31 quarters.
  • Janney Montgomery Scott's SANGAMO THERAPEUTICS INC position peaked at $586K in Q3 2021.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Janney Montgomery Scott's 13F filing for Q4 2022, filed 1 Feb 2023.